tradingkey.logo

Surmodics Inc

SRDX

36.330USD

+0.300+0.83%
交易中 美东报价延迟15分钟
519.48M总市值
亏损市盈率 TTM

Surmodics Inc

36.330

+0.300+0.83%
关于 Surmodics Inc 公司
Surmodics, Inc. 是血管内医疗器械高性能涂层技术以及体外诊断免疫测定测试和微阵列化学和生物组件的供应商。该公司还开发和销售高度差异化的血管介入医疗器械,这些医疗器械旨在满足尚未满足的临床需求,并根据苛刻的要求进行设计。其部门包括医疗器械和 IVD。医疗器械部门制造和授权高性能涂层,包括表面改性涂层技术,以改善医疗器械的可及性、可输送性和可预测性部署,以及药物输送涂层技术,以从医疗器械表面提供特定部位的药物输送,终端市场包括神经血管、外周和冠状动脉。IVD 部门制造用于诊断和生物医学研究市场中的体外诊断免疫测定和分子测试的化学和生物组件。
公司简介
公司代码SRDX
公司名称Surmodics Inc
上市日期Mar 04, 1998
CEOMr. Gary R. Maharaj
员工数量389
证券类型Ordinary Share
年结日Mar 04
公司地址9924 W 74th St
城市EDEN PRAIRIE
上市交易所NASDAQ Global Select Consolidated
国家United States of America
邮编55344
电话19525007000
网址https://www.surmodics.com/
公司代码SRDX
上市日期Mar 04, 1998
CEOMr. Gary R. Maharaj
公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Gary R. Maharaj
Mr. Gary R. Maharaj
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
192.06K
-2.07%
Mr. Timothy J. Arens
Mr. Timothy J. Arens
Chief Financial Officer, Senior Vice President - Finance and Information Technology
Chief Financial Officer, Senior Vice President - Finance and Information Technology
67.30K
-1.84%
Mr. Joseph J. Stich
Mr. Joseph J. Stich
Senior Vice President of Human Resources, President - In Vitro Diagnostics
Senior Vice President of Human Resources, President - In Vitro Diagnostics
59.53K
-1.71%
Mr. Charles W. Olson
Mr. Charles W. Olson
Senior Vice President, President - Medical Device Coatings
Senior Vice President, President - Medical Device Coatings
52.28K
-1.80%
Dr. David R. Dantzker, M.D.
Dr. David R. Dantzker, M.D.
Independent Director
Independent Director
40.18K
+2.71%
Ms. Susan E. (Sue) Knight
Ms. Susan E. (Sue) Knight
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
37.24K
+5.95%
Mr. Jose H. Bedoya
Mr. Jose H. Bedoya
Independent Director
Independent Director
30.01K
+3.63%
Mr. Gordon S. Weber, J.D.
Mr. Gordon S. Weber, J.D.
Senior Vice President - Legal, General Counsel, Secretary
Senior Vice President - Legal, General Counsel, Secretary
21.04K
-1.49%
Ms. Lisa Wipperman Heine
Ms. Lisa Wipperman Heine
Independent Director
Independent Director
13.98K
+3.90%
Ms. Teryl L.W. Sides
Ms. Teryl L.W. Sides
Senior Vice President, President - Vascular Interventions
Senior Vice President, President - Vascular Interventions
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Gary R. Maharaj
Mr. Gary R. Maharaj
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
192.06K
-2.07%
Mr. Timothy J. Arens
Mr. Timothy J. Arens
Chief Financial Officer, Senior Vice President - Finance and Information Technology
Chief Financial Officer, Senior Vice President - Finance and Information Technology
67.30K
-1.84%
Mr. Joseph J. Stich
Mr. Joseph J. Stich
Senior Vice President of Human Resources, President - In Vitro Diagnostics
Senior Vice President of Human Resources, President - In Vitro Diagnostics
59.53K
-1.71%
Mr. Charles W. Olson
Mr. Charles W. Olson
Senior Vice President, President - Medical Device Coatings
Senior Vice President, President - Medical Device Coatings
52.28K
-1.80%
Dr. David R. Dantzker, M.D.
Dr. David R. Dantzker, M.D.
Independent Director
Independent Director
40.18K
+2.71%
Ms. Susan E. (Sue) Knight
Ms. Susan E. (Sue) Knight
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
37.24K
+5.95%
收入明细
单位: USD更新时间: 7月6日 周日
单位: USD更新时间: 7月6日 周日
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
暂无数据
地区USD
名称
营收
占比
Domestic
104.64M
83.00%
Foreign
21.43M
17.00%
业务
地区
暂无数据
股东统计
更新时间: 7月17日 周四
更新时间: 7月17日 周四
持股股东
股东类型
持股股东
持股股东
占比
BlackRock Institutional Trust Company, N.A.
7.32%
AllianceBernstein L.P.
5.94%
The Vanguard Group, Inc.
5.59%
Soleus Capital Management, L.P.
5.52%
Gabelli Funds, LLC
5.03%
Other
70.61%
持股股东
持股股东
占比
BlackRock Institutional Trust Company, N.A.
7.32%
AllianceBernstein L.P.
5.94%
The Vanguard Group, Inc.
5.59%
Soleus Capital Management, L.P.
5.52%
Gabelli Funds, LLC
5.03%
Other
70.61%
股东类型
持股股东
占比
Investment Advisor/Hedge Fund
38.66%
Investment Advisor
23.46%
Hedge Fund
22.11%
Individual Investor
3.88%
Research Firm
3.84%
Bank and Trust
0.51%
Sovereign Wealth Fund
0.22%
Pension Fund
0.11%
Insurance Company
0.03%
Other
7.18%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
318
12.56M
87.87%
-3.96M
2025Q1
343
12.58M
88.00%
-4.09M
2024Q4
362
12.66M
88.58%
-3.97M
2024Q3
348
12.66M
88.74%
-3.48M
2024Q2
329
13.91M
98.26%
-1.49M
2024Q1
308
13.31M
93.49%
-1.66M
2023Q4
311
13.68M
96.13%
-630.83K
2023Q3
314
12.98M
91.82%
-1.55M
2023Q2
312
12.97M
91.74%
-1.29M
2023Q1
318
13.21M
93.54%
-785.00K
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
BlackRock Institutional Trust Company, N.A.
1.05M
7.32%
+6.42K
+0.62%
Mar 31, 2025
AllianceBernstein L.P.
849.35K
5.94%
-161.91K
-16.01%
Mar 31, 2025
The Vanguard Group, Inc.
798.67K
5.59%
-4.62K
-0.58%
Mar 31, 2025
Soleus Capital Management, L.P.
789.06K
5.52%
+50.00K
+6.77%
Mar 31, 2025
Gabelli Funds, LLC
719.00K
5.03%
+105.85K
+17.26%
Mar 31, 2025
Hudson Bay Capital Management LP
464.97K
3.25%
+164.97K
+54.99%
Mar 31, 2025
Morgan Stanley Investment Management Inc. (US)
428.97K
3%
+236.16K
+122.48%
Mar 31, 2025
Qube Research & Technologies Ltd
389.19K
2.72%
-64.84K
-14.28%
Mar 31, 2025
State Street Global Advisors (US)
362.24K
2.53%
-11.29K
-3.02%
Mar 31, 2025
查看更多
持股ETF
更新时间: 8月2日 周六
更新时间: 8月2日 周六
机构名称
占比
First Trust Merger Arbitrage ETF
2.59%
SPDR S&P Health Care Equipment ETF
0.39%
Inspire Small/Mid Cap ESG ETF
0.19%
iShares Micro-Cap ETF
0.09%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.08%
iShares U.S. Medical Devices ETF
0.05%
Franklin US Small Cap Multifactor Index ETF
0.05%
iShares Russell 2000 Growth ETF
0.03%
Proshares Ultra Russell 2000
0.02%
ProShares Hedge Replication ETF
0.02%
查看更多
First Trust Merger Arbitrage ETF
占比2.59%
SPDR S&P Health Care Equipment ETF
占比0.39%
Inspire Small/Mid Cap ESG ETF
占比0.19%
iShares Micro-Cap ETF
占比0.09%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
占比0.08%
iShares U.S. Medical Devices ETF
占比0.05%
Franklin US Small Cap Multifactor Index ETF
占比0.05%
iShares Russell 2000 Growth ETF
占比0.03%
Proshares Ultra Russell 2000
占比0.02%
ProShares Hedge Replication ETF
占比0.02%
分红派息
近5年累计派现 0.00 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
tradingkey.logo
tradingkey.logo
日内数据由路孚特(Refinitiv)提供,并受使用条款约束。历史及当前收盘数据均由路孚特提供。所有报价均以当地交易所时间为准。美股报价的实时最后成交数据仅反映通过纳斯达克报告的交易。日内数据延迟至少15分钟或遵循交易所要求。
* 参考、分析和交易策略由第三方提供商Trading Central提供,观点基于分析师的独立评估和判断,未考虑投资者的投资目标和财务状况。
风险提示:我们的网站和移动应用程序仅提供关于某些投资产品的一般信息。Finsights 不提供财务建议或对任何投资产品的推荐,且提供此类信息不应被解释为 Finsights 提供财务建议或推荐。
投资产品存在重大投资风险,包括可能损失投资的本金,且可能并不适合所有人。投资产品的过去表现并不代表其未来表现。
Finsights 可能允许第三方广告商或关联公司在我们的网站或移动应用程序的任何部分放置或投放广告,并可能根据您与广告的互动情况获得报酬。
© 版权所有: FINSIGHTS MEDIA PTE. LTD. 版权所有
KeyAI